← Leaderboards
Katherine Elizabeth Burdick
Brigham And Women'S Hospital
$8,386,418
Attributed
$11,858,020
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,858,020 · 7
VA$0 · 1
By mechanism
R01$10,238,513 · 4
K23$774,257 · 1
R34$762,750 · 1
R03$82,500 · 1
I01$0 · 1
Top collaborators
- Faith M. Gunning5 shared
- Hadine Joffe3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Mark G Baxter$13,760,448
- Sylvain Bouix$7,506,811
- Chance Marion John Luckey$8,391,345
- Hadine Joffe$12,089,762
- John W Winkelman$2,642,080
Others in their field
Top investigators on “Bipolar Disorder”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$104,882,091
- Boris Birmaher · University Of Pittsburgh At Pittsburgh$36,811,175
- Francine M. Benes · Mc Lean Hospital (Belmont, Ma)$24,902,479
- Nelson B Freimer · University Of California Los Angeles$23,891,380
- Carlos N Pato · Rutgers Biomedical And Health Sciences$21,383,759
- Brian David Athey · University Of Michigan At Ann Arbor$21,292,399
Research focus
Bipolar DisorderBaseCognitiveSamplingTraitImpairmentAttentionFutureSchizophreniaNeurocognitionNeurocognitiveFunctional DisabilityDisease RemissionPerformanceExecutive FunctionHeterogeneitySocialAffectiveFunctional DisorderDesignImpaired CognitionAffective SymptomsNeurocognitive DeficitPhenotype
Grant awards (32)
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage$924,035
R01 · FY2025 · MH
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders$805,502
R01 · FY2025 · MH · contact PI
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders$811,064
R01 · FY2024 · MH · contact PI
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage$925,688
R01 · FY2023 · MH
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders$815,689
R01 · FY2023 · MH · contact PI
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage$947,753
R01 · FY2022 · MH
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders$821,249
R01 · FY2022 · MH · contact PI
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders$892,224
R01 · FY2021 · MH · contact PI
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach$0
I01 · FY2019 · VA · contact PI
Understanding the neurocognitive heterogeneity in bipolar disorder$443,750
R01 · FY2017 · MH · contact PI
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach$0
I01 · FY2017 · VA · contact PI
Understanding the Neurocognitive Heterogeneity in Bipolar Disorder$423,750
R01 · FY2016 · MH · contact PI
1/2-Pramipexole in Bipolar Disorder:Targeting Cognition (PRAM)-BD$275,876
R01 · FY2016 · MH · contact PI
1/2-Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)$117,933
R01 · FY2016 · MH · contact PI
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach$0
I01 · FY2016 · VA · contact PI
Understanding the Neurocognitive Heterogeneity in Bipolar Disorder$423,750
R01 · FY2015 · MH · contact PI
1/2-Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)$381,375
R01 · FY2015 · MH · contact PI
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder with Modafinil$254,250
R34 · FY2015 · MH · contact PI
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach$0
I01 · FY2015 · VA · contact PI
Understanding the Neurocognitive Heterogeneity in Bipolar Disorder$423,750
R01 · FY2014 · MH · contact PI
1/2-Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)$381,375
R01 · FY2014 · MH · contact PI
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder with Modafinil$254,250
R34 · FY2014 · MH · contact PI
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach$0
I01 · FY2014 · VA · contact PI
Understanding the Neurocognitive Heterogeneity in Bipolar Disorder$423,750
R01 · FY2013 · MH · contact PI
Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder with Modafinil$254,250
R34 · FY2013 · MH · contact PI
Neurocognition as an endophenotype in bipolar disorder$162,275
K23 · FY2012 · MH · contact PI
Neurocognition as an endophenotype in bipolar disorder$84,577
K23 · FY2011 · MH · contact PI
Neurocognition as an endophenotype in bipolar disorder$69,835
K23 · FY2011 · MH · contact PI
Neurocognition as an endophenotype in bipolar disorder$155,393
K23 · FY2010 · MH · contact PI
Neurocognition as an endophenotype in bipolar disorder$152,380
K23 · FY2009 · MH · contact PI
Neurocognition as an endophenotype in bipolar disorder$149,797
K23 · FY2008 · MH · contact PI
Correlates of Suicidal Ideation in Bipolar Disorder$82,500
R03 · FY2007 · MH · contact PI